» Articles » PMID: 36660249

Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation

Overview
Specialty Pharmacology
Date 2023 Jan 20
PMID 36660249
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The network pharmacology analysis, molecular docking and experimental verification were performed to explore the pharmacological mechanisms of Sancao Yuyang Decoction (SCYYD) in the treatment of oral mucositis (OM).

Methods: Active ingredients in SCYYD and their potential targets, as well as OM-related targets were screened from public databases. The core targets and signaling pathways of SCYYD against OM were determined by protein-protein interaction (PPI) network, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. The ingredient-target-disease network and target-pathway network were constructed. Subsequently, molecular docking was carried out to predict the binding activity between active ingredients and key targets. Moreover, in vivo experiment was conducted to further verify the core targets predicted by network pharmacology analysis.

Results: A total of 119 bioactive ingredients were screened from the corresponding databases. One hundred and eighty-six putative targets were retrieved and bioinformatics analysis was performed to reveal the top 5 potential candidate agents and 10 core targets. GO and KEGG enrichment analysis showed that SCYYD exerted excellent therapeutic effects on OM through several pathways, such as HIF-1 and Ras signaling pathway. Subsequently, molecular docking showed that main ingredients in SCYYD had optimal binding activities to the key protein targets. Moreover, the result of in vivo experiment indicated that SCYYD not only inhibited inflammation response and promoted wound healing of oral mucosa in OM rats, but also reversed high expressions of SRC, HSP90AA1, STAT3, HIF1α, mTOR, TLR4, MMP9, and low expression of ESR1.

Conclusion: This study preliminarily uncovered the multiple compounds and multiple targets of SCYYD against OM using network pharmacology, molecular docking and in vivo verification, which provided a new insight of the pharmacological mechanisms of SCYYD in treatment of OM.

Citing Articles

Alisol A, the Eye-Entering Ingredient of , Relieves Macular Edema Through TNF-α as Revealed by UPLC-Triple-TOF/MS, Network Pharmacology, and Zebrafish Verification.

Shen R, Cheng K, Li G, Pan Z, Qiaolongbatu X, Wang Y Drug Des Devel Ther. 2024; 18:3361-3382.

PMID: 39100223 PMC: 11297588. DOI: 10.2147/DDDT.S468119.

References
1.
Geng Q, Liu R, Shen Z, Wei Q, Zheng Y, Jia L . Transcriptome sequencing and metabolome analysis reveal the mechanism of Shuanghua Baihe Tablet in the treatment of oral mucositis. Chin J Nat Med. 2021; 19(12):930-943. DOI: 10.1016/S1875-5364(22)60150-X. View

2.
Pulito C, Cristaudo A, La Porta C, Zapperi S, Blandino G, Morrone A . Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020; 39(1):210. PMC: 7542970. DOI: 10.1186/s13046-020-01715-7. View

3.
Wang S, Cao M, Xu S, Shi J, Mao X, Yao X . Luteolin Alters Macrophage Polarization to Inhibit Inflammation. Inflammation. 2019; 43(1):95-108. DOI: 10.1007/s10753-019-01099-7. View

4.
Zhang R, Zhu X, Bai H, Ning K . Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Front Pharmacol. 2019; 10:123. PMC: 6393382. DOI: 10.3389/fphar.2019.00123. View

5.
Zhou W, Zhang H, Wang X, Kang J, Guo W, Zhou L . Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis. Phytomedicine. 2021; 95:153837. DOI: 10.1016/j.phymed.2021.153837. View